Ultragenyx Pharmaceutical Inc. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 82.77 | 1,226 | 101,476 | 14,181 | 15.4 K to 14.2 K (-7.96 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 85.31 | 649 | 55,366 | 15,407 | 16.1 K to 15.4 K (-4.04 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 4,875 | 1.9 K to 4.9 K (+160.00 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Grant | A | 0.00 | 3,000 | 0 | 11,750 | 8.8 K to 11.8 K (+34.29 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 3,000 | 0 | 76,360 | 73.4 K to 76.4 K (+4.09 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
Jun 15 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Option Exercise | M | 21.00 | 2,955 | 62,055 | 19,448 | |
Jun 15 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Sell | S | 83.70 | 955 | 79,934 | 11,940 | 12.9 K to 11.9 K (-7.41 %) |
Jun 15 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Buy | M | 21.00 | 2,955 | 62,055 | 12,895 | 9.9 K to 12.9 K (+29.73 %) |
Jun 15 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Option Exercise | M | 21.00 | 2,955 | 62,055 | 19,448 | |
Jun 15 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Sell | S | 83.70 | 955 | 79,934 | 11,940 | 12.9 K to 11.9 K (-7.41 %) |
Jun 15 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Buy | M | 21.00 | 2,955 | 62,055 | 12,895 | 9.9 K to 12.9 K (+29.73 %) |
Jun 13 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Sell | S | 76.97 | 1,338 | 102,986 | 9,940 | 11.3 K to 9.9 K (-11.86 %) |
Jun 07 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 0.82 | 3,350 | 2,730 | 22,313 | |
Jun 07 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 80.07 | 6,700 | 536,456 | 53,478 | 60.2 K to 53.5 K (-11.13 %) |
Jun 07 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 0.82 | 3,350 | 2,730 | 60,178 | 56.8 K to 60.2 K (+5.89 %) |
Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 73.73 | 346 | 25,511 | 56,828 | 57.2 K to 56.8 K (-0.61 %) |
Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 73.73 | 260 | 19,170 | 16,124 | 16.4 K to 16.1 K (-1.59 %) |
Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 73.73 | 294 | 21,677 | 23,830 | 24.1 K to 23.8 K (-1.22 %) |
Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 73.73 | 346 | 25,511 | 83,114 | 83.5 K to 83.1 K (-0.41 %) |
Jun 04 2018 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 73.73 | 926 | 68,274 | 450,472 | 451.4 K to 450.5 K (-0.21 %) |
Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Payment of Exercise | F | 73.73 | 260 | 19,170 | 18,330 | 18.6 K to 18.3 K (-1.40 %) |